Jennifer Chien

2021

In 2021, Jennifer Chien earned a total compensation of $2.1M as Executive Vice President, Head of North America at RHYTHM PHARMACEUTICALS, a 14% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$190,864
Option Awards$931,613
Salary$395,000
Stock Awards$552,376
Other$11,600
Total$2,081,452

Chien received $931.6K in option awards, accounting for 45% of the total pay in 2021.

Chien also received $190.9K in non-equity incentive plan, $395K in salary, $552.4K in stock awards and $11.6K in other compensation.

Rankings

In 2021, Jennifer Chien's compensation ranked 5,901st out of 12,415 executives tracked by ExecPay. In other words, Chien earned more than 52.5% of executives.

ClassificationRankingPercentile
All
5,901
out of 12,415
53rd
Division
Manufacturing
2,492
out of 5,501
55th
Major group
Chemicals And Allied Products
1,083
out of 2,371
54th
Industry group
Drugs
964
out of 2,092
54th
Industry
Pharmaceutical Preparations
693
out of 1,542
55th
Source: SEC filing on April 27, 2023.

Chien's colleagues

We found four more compensation records of executives who worked with Jennifer Chien at RHYTHM PHARMACEUTICALS in 2021.

2021

David Meeker

RHYTHM PHARMACEUTICALS

Chief Executive Officer

2021

Hunter Smith

RHYTHM PHARMACEUTICALS

Chief Financial Officer

2021

Yann Mazabraud

RHYTHM PHARMACEUTICALS

Executive Vice President, Head of International

2021

Joseph Shulman

RHYTHM PHARMACEUTICALS

Chief Technical Officer

News

You may also like